SUBSTITUTUED QUINOXALINES AS FGFR KINASE INHIBITORS

摘要

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.